For the Inventor, By the Inventor

Enter assignee name

Zurich, Switzerland

Xeltis Ag

USPTO Granted Patents = 17

EPO Patents = 13

Forward Citations = 4

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Martijn Antonius Johannes Cox (11 out of 16 patents)

Mohammed S El-Kurdi (5 out of 24 patents)

Jon McGrath (4 out of 18 patents)

4. Anandkumar Nandakumar (3 out of 4 patents)

5. Youssef Biadillah (2 out of 37 patents)

6. Aurelie Serrero (2 out of 2 patents)

7. Tristan Mes (2 out of 9 patents)

8. Anton Willem Bosman (2 out of 24 patents)

9. Tom Lavrijsen (2 out of 5 patents)

10. J Christopher Flaherty (2 out of 267 patents)

11. Christophe Pierre Edouard Naz (2 out of 2 patents)

12. Franciscus Petrus Thomas Baaijens (2 out of 12 patents)

13. Patricia Yvonne Wilhelmina Dankers (2 out of 8 patents)

14. Carolina Victoria Catharina Bouten (2 out of 3 patents)

15. Kermit Santiago (2 out of 2 patents)

17 patents: Sort by Forward Citations

1. 12746116 - Reinforced heart valve leaflets (2026-09-29),

2. 12740862 - Medical device using bioabsorbable material (2026-09-22),

3. 12508125 - Electrospun suture ring (2025-12-30),

4. 12472053 - Multiple layer vascular graft (2025-11-18),

5. 12303384 - Electrospun heart valves (2025-05-20),

6. 12109759 - System for producing a graft device with a three dimensional covering (2024-10-08),

7. 12017413 - System for producing a graft device with a three dimensional covering (2024-06-25),

8. 11980535 - Method of using a cardiovascular graft to reduce thrombosis or platelet adhesion (2024-05-14),

9. 11872134 - Medical device using bioabsorbable material (2024-01-16),

10. 11767613 - Medical implant preform produced using an inside out flipping method (2023-09-26),

11. 11744591 - Medical device for anastomosis (2023-09-05),

12. 11452624 - Implant (2022-09-27),

13. 10953139 - Electro-spun cardiovascular implant (2021-03-23),

14. 10905796 - Supramolecular polymer blend (2021-02-02),

15. 10876222 - Methods for electrospin coating and laminating of endoluminal prostheses (2020-12-29),

Xeltis is a medical technology company that focuses on developing heart valves and blood vessels made from the body's own materials, eliminating the need for lifelong medication and repeat surgeries. Their products are designed to restore natural functions and provide long-lasting solutions for patients with cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

17 Patents

#51 in Zurich

#723 in Switzerland

#35,857 in the World

Zurich, Switzerland

Xeltis Ag

Forward Citations = 4

50 inventors:

Martijn Antonius Johannes Cox (11 out of 16 patents)

Mohammed S El-Kurdi (5 out of 24 patents)

Jon McGrath (4 out of 18 patents)

4. Anandkumar Nandakumar (3 out of 4 patents)

5. Youssef Biadillah (2 out of 37 patents)

Please report any incorrect information to [email protected]

Loading…